Drug Companies News
Trump's HHS Pick, Tom Price, Grilled About His Stock Trades While Working on Health Legislation
Rep. Tom Price, R-Georgia, Donald Trump's pick to lead the Department of Health and Human Services, told senators in a confirmation hearing today that the incoming Trump administration aims to prevent Americans from losing their health care in a transition from the current system to any GOP
Price Tries to Reassure on Health Care; Dems Not Buying It
President-elect Donald Trump's pick for health secretary says new administration won't pull the rug out from people covered under "Obamacare."
Trump Cabinet Members in the Hot Seat
ABC News' Maggie Rulli takes you behind the scenes on Capitol Hill where Senate confirmation hearings are underway for the Trump administration.
Adobe and CoLucid Pharma Edge Higher While Target Skids
Adobe Systems and CoLucid Pharmaceuticals rise and Target in U.S. trading, while Nordstrom and Northern Trust fall
Pointed Questions Await Trump's Pick for Health Secretary
Congressman Tom Price is facing pointed questions about President-elect Donald Trump's health policies and his own investments in health care companies
Donald Trump Promises to Replace Obamacare With 'Insurance for Everybody'
Trump has not given details but vows not to cut Medicare and to negotiate with drug companies to lower prices.
What You Need to Know About the Deadly 'Superbug' Infection Resistant to All FDA-Approved Antibiotics
The rise of drug-resistant bacterial "superbugs" have been a concern of public health officials for years, but the U.S. Centers for Disease Control and Prevention has reported a worse-case scenario -- a woman with a bacterial infection that was resistant to all FDA-approved treatments. A Nevada
Trump on Obamacare, Drug Companies and CIA Chief John Brennan
ABC News' Jon Karl weighs in on the president-elect's transition and tumultuous relationship with the intelligence community.
Protests Shutdown Far-Right Speaker at UC Davis
Speeches by far-right commentator Milo Yiannopoulos (yuh-NAH'-poh-lihs) and former pharmaceutical executive Martin Shkreli were canceled after heated protests erupted at the University of California, Davis
As Talks Loom, 'Hard Brexit' Option Raises Fear of Tariffs
As Britain gears up to starts talks to leave the European Union, the possibility of a 'hard' exit is spooking investors and some political and business leaders